Hanmi wins Viagra’s design trials
A Hanmi Pharm’s erectile dysfunction treatment, Palpal was finally confirmed not to infringe the Viagra’s trademark right.
On the 18th, the 4th Civil Division, Seoul High Court, dismissed the plaintiff’s appeal in the remand after reversal of the trial against infringement of the design right, f...
Fees
- Email service daily and homepage access.
- $300 per month. ($3,240 per year)
- 5 Email holders per each company.
- Anual contract base.
